Project Grant R21AI186344
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$424K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38103, USA
Similar Awards
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to develop an immunocompetent ferret model to study the spinal pathology associated with Enterovirus D68 (EV-D68) infection and acute flaccid myelitis (AFM). The $217,976 award, effective from February 1, 2025 to January 31, 2027, will enable the grantee, The Henry M. Jackson Foundation for...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $155,454 to Washington University to conduct research on the molecular basis of receptor interactions for Venezuelan Equine Encephalitis Virus (VEEV). The key objectives are to identify alternative entry receptors for VEEV beyond the recently discovered primary receptor LDLRAD3, and to improve the therapeutic potential...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $360,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Virginia Polytechnic Institute & State University (Virginia Tech) to develop a gerbil model to delineate the mechanism of Hepatitis E Virus (HEV) extrahepatic pathogenesis. The key objectives are to: 1) Determine the effect of HEV-3-induced pyroptosis in neurovascular unit (NVU) cells and identify the mechanisms of...
The University of Wisconsin System will use a $1,352,220 cooperative agreement award from the United States Department of Agriculture Animal and Plant Health Inspection Service to expand knowledge of species susceptibility to SARS-CoV-2 and develop mosaic vaccines that protect against multiple SARS-CoV-2 variants. The award, provided under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025), will support genetic immunization experiments in ferrets to...
This Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $128,052 to Virginia Polytechnic Institute & State University (Virginia Tech) to investigate the role of the Rift Valley Fever Virus (RVFV) non-structural small (NSS) protein in modulating the host autophagy pathway. The project aims to define the molecular mechanism of the NSS-LC3 interaction and assess its impact...
This $583,047 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how Rift Valley Fever Virus (RVFV) disseminates from the site of infection in the skin to the central nervous system (CNS). The project aims to establish the routes and mechanisms by which RVFV invades the CNS following peripheral exposure, using novel rodent CNS infection models...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $835,137 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the Icahn School of Medicine at Mount Sinai. The goal of this 5-year project is to develop a repository of 50 monoclonal antibodies (25 anti-hamster and 25 anti-guinea pig) that can be used to study immune and inflammatory responses in hamster and guinea pig animal models, which are important for researching infectious...
This Project Grant award of $536,871 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to identify pan-arenavirus sites of vulnerability through machine learning and artificial neural network molecular screening of small molecules against arenavirus glycoprotein complexes (GPC) and RNA polymerases (RNAP). The proposed research seeks to define molecular specificities and commonalities across...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the mechanisms by which influenza infection can protect against malaria-associated respiratory distress syndrome (MA-ARDS) in mice. The $224,070 award to the University of Utah aims to determine how influenza modifies pulmonary vascular endothelial cells and induces arginase 1-producing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $626,423 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas Medical Branch at Galveston (UTMB). The funding will support research to explore the dependence of arenaviruses on the metabolism of the monosaccharides D-glucose and D-mannose, with the goal of developing carbohydrate antimetabolite compounds as potential pan-arenavirus therapeutics. Specifically,...